Understood reports that the FDA has approved Simtriyo, a new ADHD medication targeting dopamine, norepinephrine, and serotonin, promising fewer side effects.

Centanafadine belongs to a new class of ADHD medicines. It’s the first to affect three brain chemicals: noradrenaline (known ...

A combination of two drugs- one for smoking cessation and another for depression- appear to work synergistically to treat alcohol use disorder. The corresponding study was published in The Lancet ...

We all know what it feels like to be motivated—that sense of eager anticipation and potent drive that propels us into action. Feelings of contentment or euphoria often accompany our peak motivational ...

An Emory University study published in Molecular Psychiatry shows levodopa, a drug that increases dopamine in the brain, has potential to reverse the effects of inflammation on brain reward circuitry, ...

People given a dopamine drug learn faster and win more often when gambling, according to new research. The study may also help explain why patients with Parkinson’s disease, who take the dopamine drug ...

The neurotransmitter dopamine is commonly known for its role in brain networks regulating pleasure and reward. But many people with disorders that affect the dopamine system, such as Parkinson’s ...

A new study from the Netherlands Institute for Neuroscience brings together two schools of thought on the function of the neurotransmitter dopamine: one saying that dopamine provides a learning signal ...

Our brains are not static objects — they adapt and reorganize to the ebb and flow of new information, sensations, and even physical trauma. But when this impressive neuroplasticity is impaired, it can ...